Trenton NJ, New Jersey Business and Industry Association (NJBIA) released its 62nd annual Business Outlook Survey , The survey as expected showed a severe COVID-19 impact, an anticipated slow recovery and an overall dissatisfaction with NJ’s business climate.
In states that are booming like Texas, Florida or Tennessee, government works to lure new investment to their states. In New Jersey, the opposite is true. 9 out of 10 New Jersey Businesses surveyed feel that our state has made no progress in easing regulatory obstacles for business.
Ridgewood NJ, Due to two recent separate positive COVID-19 cases of unknown origin, Orchard Elementary School will transition to all remote learning tomorrow, Tuesday, December 1, 2020. In person instruction will resume on Tuesday December 15, 2020. Orchard Elementary School students should not participate in out of school activities during this time of remote learning. The situation is fluid and updated information from the NJDOH may alter this return date.
CAMBRIDGE Mass , Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a vaccine efficacy of 94.1%. Safety data continue to accrue and the study continues to be monitored by an independent, NIH-appointed Data Safety Monitoring Board (DSMB). The Company also announced that today, Moderna plans to request an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA). The Phase 3 study, known as the COVE study, enrolled more than 30,000 participants in the U.S. and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.
Ridgewood NJ, Due to two recent separate positive COVID-19 cases of unknown origin, Hawes Elementary School will transition to all remote learning tomorrow, Monday, November 30, 2020. In-person instruction will resume on Thursday, December 10, 2020. Hawes Elementary School students should not participate in out-of-school activities during this time of remote learning. The situation is fluid and updated information from the NJDOH may
alter this return date.
Trenton NJ, Statement from Department of Health Communications Director Donna Leusner
“An employee working in the Commissioner’s Office recently tested positive for COVID-19. The employee was last in the building on Tuesday, November 24 and is currently isolating at home.
Ridgewood NJ, Johns Hopkins University Newsletter ran a study from Genevieve Briand, assistant program director of the Applied Economics master’s degree program at Hopkins, that looked at the effect of COVID-19 on U.S. deaths according to data from the CDC. Dr. Genevieve Briand at Johns Hopkins University noted some critical accounting errors done at the national level.
Ridgewood NJ, Due to two recent separate positive COVID-19 cases of unknown origin, Willard Elementary School will transition to all remote learning, Monday, November 30, 2020. In-person instruction will resume on Thursday, December 10, 2020. Willard Elementary School students should not participate in out-of-school activities during this time of remote learning. The situation is fluid and updated information from the NJDOH may alter this return date.
Ridgewood NJ, previously reported on the Ridgewood blog that AstraZeneca issued a press release regarding preliminary results from the Phase 3 clinical trials of its candidate SARS-CoV-2 vaccine, developed in collaboration with Oxford University (UK). According to Johns Hopkins Center for Health Security ,the press release indicates that the vaccine demonstrated 90% efficacy when administered as an initial half-dose followed by a full dose a month later. Interestingly, however, the vaccine was 62% efficacious in participants who received 2 full doses over the same period of time, resulting in an overall efficacy of 70%. No serious adverse events were identified in the trials. In total, the Phase 3 portion of the trials included more than 11,000 participants, and the researchers identified 131 COVID-19 cases. As has been the case throughout the pandemic, the data published via press release have not yet been peer reviewed, although the researchers reportedly intend to publish the full data in the near future.
Crest Pointe Rehabilitation and Health Care Center in Point Pleasant Admitting New COVID Positive Patients After 19 Residents Died
the staff of the Ridgewood blog
Point Pleasant NJ, Senator Joe Pennacchio continues to question the administration and State Department of Health’s policy toward admittance of new COVID patients at long-term nursing facilities.
The Senator’s office received an anonymous call from a resident’s loved one who heard that the center was still accepting new patients who are testing positive for COVID. Office staff confirmed with the nursing home’s admissions office that new patients testing positive for COVID are in fact being admitted.
Ridgewood NJ, according to Johns Hopkins Center for Health Security , the US FDA issued an Emergency Use Authorization (EUA) for another monoclonal antibody treatment for COVID-19. The newest EUA is for a combination therapy using casirivimab and imdevimab, developed by Regeneron Pharmaceuticals, which are monoclonal antibodies that target the receptor binding domain for the SARS-CoV-2 spike protein. Similar to the previous FDA EUA for the Eli Lilly monoclonal antibody treatment, this combination is authorized for use in mild or moderate COVID-19 patients (aged 12 years and older) who are not currently hospitalized but who are at high risk of progressing to severe disease. It is not authorized for patients who are currently hospitalized or receiving supplemental oxygen therapy for COVID-19 or an underlying health condition. The 2 products must be administered together.
Paramus NJ, The County of Bergen, in collaboration with Bergen New Bridge Medical Center will extend their COVID-19 testing efforts by launching a new drive-thru program at Bergen Community College located at 400 Paramus Rd, Paramus, N.J.
Dear Paramus Community,
Throughout this school year, our approach to designing, implementing, and adjusting our learning models has remained consistent in its prioritization of health and safety above all else. As a community, we have come together in our adherence to the enhanced health and safety protocols that have allowed our school buildings to remain safe places for our staff and in-person students to participate in the learning process. While we have needed to implement COVID-19 related quarantines of student and staff groups (you may view data related to these quarantines on the district’s new COVID-19 Quarantine Dashboard), our number of confirmed in-school transmissions of COVID-19 remains at zero.
Washington DC, The U.S. Supreme Court on Wednesday night blocked New York Gov. Andrew Cuomo from reimposing strict attendance caps at worship services in areas hit hard by the novel coronavirus.
The court ruled 5-4 to bar Cuomo from enforcing his Oct. 6 “Cluster Initiative” against houses of worship that sued to challenge the restrictions.
Cuomo’s initiative had created color-coded limits on mass gatherings and business operations, in an effort to stem the outbreak in New York City areas that were experiencing a surge in cases, according to Bloomberg News.
